Search results
Displaying 11 - 20 of 86 results
-
Evaluation of the safe use of opioids national collaborative
This report presents an evaluation of the Health Quality & Safety Commission-led safe use of opioids national collaborative.
-
Oxycodone: How did we get here and how do we fix it
This article from Best Practice Journal (July 2014) 'How did we get here and how do we fix it' focuses on the increase in prescribing of oxycodone.
- Video: Introducing the safe use of opioids collaborative
-
ALERT: Colour coded wristbands
There is no uniform approach in New Zealand to the colours used to indicate different risks, e.g. red bands are used to indicate different risks in three different DHBs; a high risk of falls, drug allergy and gas inserted into the eye during retinal
-
New dosing guidelines for the treatment of paracetamol overdose and toxicity
The National Poisons Centre has issued new dosing guidance for acetylcysteine for the treatment of paracetamol overdose and toxicity.
- ALERT 7: Morphine
-
Injectable phenytoin incidents – risk of death and severe harm
NHS Improvement has released an alert to improve the safe use of injectable phenytoin.
-
ALERT 17: Alteplase or tenecteplase?
An alert has been issued to highlight the need to clearly differentiate between stroke thrombolysis and myocardial infarction thrombolysis.
-
Reducing opioid-related harm and building quality improvement capability in New Zealand: a national formative collaborative
This poster 'Reducing opioid-related harm and building quality improvement capability in New Zealand: a national formative collaborative' was presented at the IHI's 28th annual national forum on quality improvement in health care.
-
Display of combination product medicines in electronic systems
Guidelines for the display of combination product medicines in electronic systems.